MedTrace Logo

Carbetocin Versus Misoprostol. A Retrospective Comparative Study

NCT04313218 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-03-18

No results posted yet for this study

Summary

Cesarean section is one of the most common surgeries practiced for save delivery of the fetus, however it is not a safe route of delivery its incidence is rising especially in high and middle income countries. The major concern is that the average blood loss during cesarean delivery is 487 ml, this amount is too close to the definition of postpartum hemorrhage by WHO as loss of 500 cc of blood in the first 24 hours after delivery making control of blood loss during cesarean delivery crucial to decrease maternal morbidities.This study aim to compare the use of misoprostol to carbetocin in reducing blood loss during cesarean section in low risk patients

Conditions

  • Cesarean Section Complications

Interventions

DRUG

Carbetocin

iv infusion of 100ug carbetocin after extraction of the fetus during cesarean section

Sponsors & Collaborators

  • Port Said University hospital

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-02-01
Completion
2020-02-28

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04313218 on ClinicalTrials.gov